SOLO PARA USO EN INVESTIGACIÓN. Datos de referencia para investigación de laboratorio. No es consejo médico; no apto para consumo humano.
Peptijournal

Comparar compuestos

Seleccione hasta 3 compuestos para comparar protocolos, mecanismos, criterios de valoración y hallazgos de seguridad en paralelo.

PopularesRetatrutide vs TirzepatideSemaglutide vs TirzepatideSemaglutide vs RetatrutideBPC-157 vs TB-500BPC-157 vs GHK-CuSermorelin vs Tesamorelin
AOD-9604
Mismo objetivo
Incluir al imprimir

Solo afecta la página impresa o el PDF. El aviso de uso exclusivo en investigación siempre se imprime.

Protocolo01
AOD-9604

Metabolismo / Peso

Viales · 2 / 5 mg

01Protocol

Viales
2 / 5 mg
Datos de dosis
Referencia de laboratorio; no indicado

02Quick calculator

Extraer (100u)

—

Concentración

—

mg/mL

03Mechanism of action

AOD-9604 is a modified fragment of the C-terminal region of human growth hormone, developed to study fat metabolism without growth hormone's growth-promoting effects.

04Study endpoints

  • It was developed by Metabolic Pharmaceuticals as a potential obesity treatment and had reached phase IIa trials by February 2002.
  • A 2026 sports-medicine review groups it with unapproved peptides that look favourable in animal models but have scarce rigorous human safety data.

05Safety & regulatory findings

  • Not approved by the FDA or EMA for any indication; research-grade material is not a medicine.
  • Listed as prohibited in sport by the World Anti-Doping Agency.
  • Reviewers warn of potential for serious harm when unapproved peptides are used outside regulatory oversight.

06Citations

2 referencias · ver